Ludovic Martinet

4.9k total citations
36 papers, 3.4k citations indexed

About

Ludovic Martinet is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ludovic Martinet has authored 36 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 17 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Ludovic Martinet's work include Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (11 papers) and Immunotherapy and Immune Responses (10 papers). Ludovic Martinet is often cited by papers focused on Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (11 papers) and Immunotherapy and Immune Responses (10 papers). Ludovic Martinet collaborates with scholars based in France, Australia and United States. Ludovic Martinet's co-authors include Mark J. Smyth, Jean‐Jacques Fournié, Jean‐Philippe Girard, Ignacio Garrido, Philippe Rochaix, Thomas Filleron, Sophie Le Guellec, Lucas Ferrari de Andrade, Rémy Poupot and Marco Colonna and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Ludovic Martinet

35 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ludovic Martinet France 23 2.5k 1.8k 739 369 157 36 3.4k
G Moldenhauer Germany 26 1.4k 0.6× 642 0.4× 815 1.1× 110 0.3× 58 0.4× 44 2.4k
Andrei I. Chapoval United States 25 3.4k 1.4× 2.0k 1.1× 645 0.9× 105 0.3× 12 0.1× 60 4.4k
Hannu Mönkkönen Finland 21 876 0.4× 1.5k 0.8× 594 0.8× 70 0.2× 19 0.1× 29 2.3k
Haifeng C. Xu Germany 24 1.2k 0.5× 713 0.4× 543 0.7× 85 0.2× 14 0.1× 60 2.4k
Christina Pfirschke United States 18 2.5k 1.0× 1.8k 1.0× 1.4k 1.9× 96 0.3× 11 0.1× 20 4.3k
Silvia Miotti Italy 30 685 0.3× 824 0.5× 1.1k 1.5× 98 0.3× 15 0.1× 59 2.4k
Catherine Sabatos-Peyton United States 13 1.2k 0.5× 1.1k 0.6× 475 0.6× 88 0.2× 8 0.1× 23 2.1k
Charles J. Dimitroff United States 32 1.3k 0.5× 713 0.4× 1.5k 2.1× 203 0.6× 7 0.0× 56 2.8k
Michael P. Rettig United States 27 1.1k 0.4× 1.4k 0.7× 977 1.3× 1.8k 4.8× 8 0.1× 122 3.5k
Hua Jiang China 35 1.3k 0.5× 2.4k 1.3× 1.2k 1.6× 183 0.5× 6 0.0× 81 3.6k

Countries citing papers authored by Ludovic Martinet

Since Specialization
Citations

This map shows the geographic impact of Ludovic Martinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludovic Martinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludovic Martinet more than expected).

Fields of papers citing papers by Ludovic Martinet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludovic Martinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludovic Martinet. The network helps show where Ludovic Martinet may publish in the future.

Co-authorship network of co-authors of Ludovic Martinet

This figure shows the co-authorship network connecting the top 25 collaborators of Ludovic Martinet. A scholar is included among the top collaborators of Ludovic Martinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludovic Martinet. Ludovic Martinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villard, Marine, Sébastien Viel, Lionel Karlin, et al.. (2025). NK Cell Immaturity and NKp30 Expression Positively Correlate with Clinical Outcome in Multiple Myeloma Patients from the IFM2009 Clinical Trial. European Journal of Immunology. 55(2). e202451191–e202451191.
2.
Morandi, Elena, Véronique Adoue, I Bernard, et al.. (2024). Impact of the Multiple Sclerosis-Associated Genetic Variant CD226 Gly307Ser on Human CD8 T-Cell Functions. Neurology Neuroimmunology & Neuroinflammation. 11(6). e200306–e200306. 3 indexed citations
3.
Kassem, Sahar, Nizar El-Murr, Nadège Carrié, et al.. (2022). SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma. Blood. 139(8). 1160–1176. 17 indexed citations
4.
Nakamura, Kyohei, Sahar Kassem, Alice Cleynen, et al.. (2018). Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment. Cancer Cell. 33(4). 634–648.e5. 167 indexed citations
5.
Blake, Stephen J., Kimberley Stannard, Jing Liu, et al.. (2016). Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy. Cancer Discovery. 6(4). 446–459. 187 indexed citations
6.
Souza-Fonseca-Guimarães, Fernando, Arabella Young, Deepak Mittal, et al.. (2015). NK cells require IL-28R for optimal in vivo activity. Proceedings of the National Academy of Sciences. 112(18). E2376–84. 76 indexed citations
7.
Martinet, Ludovic & Mark J. Smyth. (2015). Balancing natural killer cell activation through paired receptors. Nature reviews. Immunology. 15(4). 243–254. 368 indexed citations
8.
Andrade, Lucas Ferrari de, Shin Foong Ngiow, Ludovic Martinet, & Mark J. Smyth. (2015). Natural Killer cell control ofBRAFV600Emutant melanoma during targeted therapy. OncoImmunology. 4(4). e998119–e998119. 4 indexed citations
9.
Andrade, Lucas Ferrari de, Shin Foong Ngiow, Kimberley Stannard, et al.. (2014). Natural Killer Cells Are Essential for the Ability of BRAF Inhibitors to Control BRAFV600E-Mutant Metastatic Melanoma. Cancer Research. 74(24). 7298–7308. 81 indexed citations
10.
Chan, Christopher J., Ludovic Martinet, Susan Gilfillan, et al.. (2014). The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nature Immunology. 15(5). 431–438. 365 indexed citations
11.
Chan, Chii Jou, Mark J. Smyth, & Ludovic Martinet. (2013). Molecular mechanisms of natural killer cell activation in response to cellular stress. Cell Death and Differentiation. 21(1). 5–14. 155 indexed citations
12.
Martinet, Ludovic, Ignacio Garrido, & Jean‐Philippe Girard. (2012). Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer. OncoImmunology. 1(5). 789–790. 36 indexed citations
13.
Martinet, Ludovic, Ignacio Garrido, Thomas Filleron, et al.. (2011). Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer. Cancer Research. 71(17). 5678–5687. 387 indexed citations
14.
Capietto, Aude-Hélène, Ludovic Martinet, & Jean‐Jacques Fournié. (2011). Stimulated γδ T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer. The Journal of Immunology. 187(2). 1031–1038. 93 indexed citations
15.
Capietto, Aude-Hélène, Ludovic Martinet, & Jean‐Jacques Fournié. (2011). How tumors might withstand γδ T-cell attack. Cellular and Molecular Life Sciences. 68(14). 2433–2442. 20 indexed citations
16.
Capietto, Aude-Hélène, Ludovic Martinet, Delphine Cendron, et al.. (2010). Phosphoantigens Overcome Human TCRVγ9+ γδ Cell Immunosuppression by TGF-β: Relevance for Cancer Immunotherapy. The Journal of Immunology. 184(12). 6680–6687. 20 indexed citations
17.
Martinet, Ludovic, Christine Jean, Gilles Dietrich, Jean‐Jacques Fournié, & Rémy Poupot. (2010). PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling. Biochemical Pharmacology. 80(6). 838–845. 108 indexed citations
18.
Martinet, Ludovic, Sandrine Fleury‐Cappellesso, Mélanie Gadelorge, et al.. (2009). A regulatory cross‐talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells. European Journal of Immunology. 39(3). 752–762. 78 indexed citations
19.
Martinet, Ludovic, Rémy Poupot, P. Mirshahi, et al.. (2009). Hospicells derived from ovarian cancer stroma inhibit T‐cell immune responses. International Journal of Cancer. 126(9). 2143–2152. 26 indexed citations
20.
Martinet, Ludovic, Rémy Poupot, & Jean‐Jacques Fournié. (2009). Pitfalls on the roadmap to γδ T cell-based cancer immunotherapies. Immunology Letters. 124(1). 1–8. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Moldenhauer Breakdown of academic impact, for papers by Andrei I. Chapoval Breakdown of academic impact, for papers by Hannu Mönkkönen Breakdown of academic impact, for papers by Haifeng C. Xu Breakdown of academic impact, for papers by Christina Pfirschke Breakdown of academic impact, for papers by Silvia Miotti Breakdown of academic impact, for papers by Catherine Sabatos-Peyton Breakdown of academic impact, for papers by Charles J. Dimitroff Breakdown of academic impact, for papers by Michael P. Rettig Breakdown of academic impact, for papers by Hua Jiang
Rankless by CCL
2026